课题基金 / 基金详情

项目摘要

项目成果

ANDREW Charles HARRIS的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请方提供):阐明补偿的潜在机制,或响应尼古丁可用性降低而发生的吸烟行为变化,对于将减少吸烟描述为管理不愿或无法戒烟的吸烟者烟草依赖的方法至关重要。我们的实验室开发了两种减少吸烟的啮齿动物模型,其中在每日尼古丁获取持续时间或每次输注尼古丁剂量减少后观察到尼古丁自我给药的代偿性增加。目前的建议将审查是否严重的负面情感(即,如通过升高的颅内自我刺激阈值评估的,尼古丁戒断的情感)后果预测了剂量或访问减少模型中的补偿。进一步的研究将检查用尼古丁特异性单克隆抗体进行被动免疫是否能有效减少补偿,这种抗体能减少尼古丁在大脑中的分布并延长药物的半衰期。表征补偿的预测因子和治疗可能有助于使用吸烟减少治疗尼古丁成瘾,也可能导致更好地理解调节吸烟行为的机制。与公共卫生的相关性:吸烟是现代世界可预防的主要死亡和疾病原因。虽然减少吸烟可能会减少香烟的有害影响,但这种策略的有效性可能会受到吸烟行为的补偿性变化(例如,增加每次吸烟的深度)的限制。拟议的研究将尝试使用两种减少吸烟的动物模型来表征诱发因素和可能的补偿治疗,将提供有关如何限制这种行为的见解,并更好地了解减少吸烟作为管理烟草依赖的方法的潜在作用。
英文摘要
DESCRIPTION (provided by applicant): Elucidating the mechanisms underlying compensation, or changes in smoking behavior that occur in response to decreased nicotine availability, is crucial for characterizing smoking reduction as an approach to managing tobacco dependence in smokers who are unwilling or unable to quit. Our laboratory has developed two rodent models of smoking reduction in which compensatory increases in nicotine selfadministration are observed following reductions in duration of daily nicotine access or nicotine dose per infusion. The current proposal will examine whether severity of the negative affective (i.e., emotional) consequences of nicotine withdrawal, as assessed by elevated intracranial self-stimulation thresholds, is predictive of compensation in either the dose or access models of reduction. Additional studies will examine whether passive immunization with a nicotine-specific monoclonal antibody, which decreases nicotine distribution to the brain and prolongs the drug's half-life, is effective in reducing compensation. Characterizing predictors and treatments for compensation may facilitate the use of smoking reduction for the treatment of nicotine addiction, and may also lead to a better understanding of the mechanisms regulating smoking behavior. Relevance to public health: Cigarette smoking is the leading preventable cause of death and disease in the modern world. Although reducing smoking may decrease the harmful effects of cigarettes, the effectiveness of this strategy may be limited by compensatory changes in smoking behavior (for example, increasing the depth of each puff) that occur following smoking reduction. The proposed studies, which will attempt to characterize predisposing factors and a possible treatment for compensation using two animal models of smoking reduction, will provide insights into how to limit this behavior and better understand the potential role of smoking reduction as an approach towards managing tobacco dependence.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.pbb.2014.05.012
发表时间: 2014-09
期刊: PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
影响因子: 3.6
作者: [Harris, Andrew C., Mattson, Christina, Shelley, David, LeSage, Mark G.]
通讯作者: LeSage, Mark G.
Comparative neurobehavioral pharmacology of combusted and non-combusted tobacco products
Comparative neurobehavioral pharmacology of combusted and non-combusted tobacco products
Comparative neurobehavioral pharmacology of combusted and non-combusted tobacco products
Animal models to inform FDA tobacco regulation: Assessing the relative abuse liability of different classes of tobacco products
海外基金